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Lipid-receptor interactionG protein-coupled receptors (GPCRs) are the largest class ofmolecules involved in signal transduction across cell
membranes and represent major targets in the development of novel drug candidates. Membrane cholesterol
plays an important role in GPCR structure and function. Molecular dynamics simulations have been successful
in exploring the effect of cholesterol on the receptor and a general consensus molecular view is emerging. We
review here recent molecular dynamics studies at multiple resolutions highlighting the main features of
cholesterol-GPCR interaction. Several cholesterol interaction sites have been identiﬁed on the receptor that are
reminiscent of nonannular sites. These cholesterol hot-spots are highly dynamic and have a microsecond time
scale of exchange with the bulk lipids. A few consensus sites (such as the CRAC site) have been identiﬁed that
correspond to higher cholesterol interaction. Interestingly, high plasticity is observed in themodes of cholesterol
interaction and several sites have been suggested to have high cholesterol occupancy. We therefore believe that
these cholesterol hot-spots are indicative of ‘high occupancy sites’ rather than ‘binding sites’. The results suggest
that the energy landscape of cholesterol association with GPCRs corresponds to a series of shallowminima inter-
connected by low barriers. These speciﬁc interactions, alongwith generalmembrane effects, have been observed
to modulate GPCR organization. Membrane cholesterol effects on receptor structure and organization, that in
turn inﬂuences receptor cross-talk and drug efﬁcacy, represent a new frontier in GPCR research. This article is
part of a Special Issue entitled: Lipid-protein interactions. Guest Editors: Amitabha Chattopadhyay and
Jean-Marie Ruysschaert.
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Gprotein-coupled receptors (GPCRs) are a superfamily ofmembrane-
embedded receptors that mediate diverse cellular responses [1,2]. As a
result of their central role in several cellular signaling networks, GPCRs
constitute the largest family of clinical drug targets [3]. The importance
of GPCRs in health and disease has led to sustained research in under-
standing various aspects of receptor function, such as ligand binding
and G-protein coupling [4,5]. An emerging aspect of GPCR research is
the recent advance in high resolution structural characterization of sever-
al GPCRs [6–10]. However, the role of membrane lipids in GPCR structure
and function still represents a relatively less explored area of research
[11].
GPCRs consist of seven transmembranehelices that traverse themem-
brane and an eighth helix that lies beneath the surface of the membrane
[12]. These receptors require cellular membranes or membrane-mimetic
environments for their function. Consequently, the receptors have been
shown to be sensitive to the membrane lipid composition [11,13,14].
An important lipid in this context is cholesterol which has been demon-
strated to modulate function of several GPCRs in a receptor-dependent
manner, including the serotonin1A receptor [15–17], the β2-adrenergic
receptor [17,18] and rhodopsin [19]. In case of the cholecystokinin re-
ceptor, ligand binding and signaling were reported to decrease upon
cholesterol depletion, but internalization and tracking were unaltered
[20]. In contrast, it has been shown that cholesterol is not essential for
the function of the neurotensin receptor 1 [21].
Membrane cholesterol has been reported to stabilize the serotonin1A
receptor [22] and modeling studies suggest that the receptor is more
compact in the presence of cholesterol [23]. In the case of the β2-
adrenergic receptor, cholesterol has been shown to improve receptor
stability and appears to be necessary for crystallization [6,8,24,25]. In
addition, the organization of the serotonin1A receptor has been demon-
strated to be cholesterol-dependent [26,27]. Interestingly, several GPCR
crystal structures have reported close interaction of the receptor with
cholesterol [6,8,10,28]. The physiological signiﬁcance of this close inter-
action is still emerging in the context of these receptors being crystal-
lized in the lipidic cubic phase [29]. As discussed above, the effect of
membrane cholesterol on GPCR organization and function appears to
be receptor-dependent, although the data set for this analysis is still
modest. A careful analysis therefore would be prudent to address the
effect of membrane cholesterol on various GPCRs.
1.1. GPCR-cholesterol interaction: direct and indirect effects
The effects of cholesterol on GPCR function and organization have
been suggested to arise due to either direct or indirect effects [30].
Direct effects are those that arise from bound lipid molecules, and affect
receptor structure and dynamics by directly interacting with it [31–33].
Indirect effects are caused due to the changes in physical properties of
the membrane that indirectly modulate receptor structure and dynam-
ics [13,34,35]. Lipidmolecules involved in a direct effect could be distin-
guished as annular and nonannular lipids [31]. Annular lipids refer to a
shell or annulus of lipid molecules surrounding the protein periphery
that interact with the receptor surface, and are exchangeable with
bulk lipids (a similar shell of lipids has been postulated to be responsible
for targeting proteins to speciﬁcmembrane domains [36]). On the other
hand, nonannular lipids are postulated to be not accessible to annular
lipids, i.e., they cannot be exchanged with annular lipids. The location
of nonannular sites correspond to inter or intramolecular (interhelical)
protein surfaces. Lipids bound to nonannular sites are considered to
possess higher speciﬁcity relative to annular lipids. It has been sug-
gested that cholesterol binding sites in GPCRs could be nonannular [37].
As stated above, indirect effects could arise from changes in the
physical properties of the membrane due to the presence or absence
of cholesterol. For example, cholesterol modulates membrane bilayer
thickness [38] and order [39], and could indirectly affect receptorfunction by inﬂuencing the dimension and rigidity of the membrane
[35]. Modulation of GPCR structure and function by hydrophobic mis-
match has been previously reported [40–42]. In addition, it has been
shown that capsaicin, which increases membrane elasticity [43], modu-
lates ligand binding activity of the hippocampal serotonin1A receptor
[44]. Recent crystal structures of GPCRs that have resolved closely
spaced cholesterol molecules [6,8,10,28] appear to support a direct
effect, which could be related to the crystallization conditions [29].
The speciﬁcity of GPCR-cholesterol interaction has been further validat-
ed from studies inwhich close structural analogs of cholesterolwere not
able to maintain receptor activity [45–47].
1.2. Multi-scale simulations
Molecular dynamics simulations have emerged as an important ap-
proach to analyze the molecular details of GPCR structure and function.
Simulations help us address questions that are difﬁcult to access with
state-of-the-art experimental approaches due to technical complexities
and challenges. Atomistic molecular dynamics simulations have been
extensively used to probe different aspects of GPCR dynamics [48].
With increasing computational power, unbiased atomistic simulations
have been used to study the activation mechanism of GPCRs at the mi-
crosecond time scale [49–51]. Using these approaches, a substantial
conformational heterogeneity has been reported to be essential for the
function of the β2-adrenergic receptor [52]. In parallel, coarse-grain
simulations are being increasingly used to explore microsecond time
scale dynamics and organization [53]. In particular, coarse-grain
simulations are proving to be useful to analyze the energetics of
GPCR association [54]. However, these studies did not explore the effect
ofmulticomponent bilayers and different bilayer constituents, especially
cholesterol.
To distinguish between direct and indirect cholesterol interactions, a
fewmolecular dynamics simulations have been performed with GPCRs
embedded in cholesterol-rich bilayers. The nanosecond time scale
regime sampled in early atomistic molecular dynamics simulations
was not able to probe lateral organization in the membrane [55–57].
Although cholesterol was suggested to be predominantly excluded
from the receptor surface [55,56], a few studies were able to identify
sites where strong contacts were observed during the simulation [57].
With increased computational resources and improvedmulti-scale sim-
ulations, longer time regimes have been simulated. Recentmicrosecond
time scale atomistic and coarse-grain simulations have been able to
sample the lateral diffusion of cholesterol. An example of a representative
GPCR, the serotonin1A receptor [58], embedded in a multi-component
bilayer containing cholesterol is shown in Fig. 1. The serotonin1A receptor
is shown in the ﬁgure with the coarse-grain force-ﬁeld, MARTINI [59,60],
that has been shown to reproduce lipid-protein interactions well
[61–63]. In these simulations, the cholesterol molecules undergo free ro-
tation and translation, and are able to interact with the receptor in an un-
biased manner. The simulations allow identiﬁcation of the cholesterol
interaction sites without an external bias, but sampling issues could be
a concern, and adequate care is needed to ensure sampling of sufﬁcient
number of binding/unbinding events. In this review, we highlight the
currentmolecular view of GPCR-cholesterol interaction utilizingmolecu-
lar dynamics simulation and how it affects GPCR structure and dynamics
by direct and indirect effects.
2. Cholesterol interaction sites: annular and nonannular
One of the longest time scale simulations was performed with
the serotonin1A receptor in 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) membrane bilayers with varying concentra-
tions of cholesterol [64]. Multiple simulations adding up to sub-
millisecond time scale regimes were performed with the receptor in
the membrane environment represented by the MARTINI coarse-grain
force-ﬁeld. During the course of the simulations, cholesterol molecules
Fig. 1. A representative snapshot of the serotonin1A receptor in a membrane bilayer of
POPC and 30% cholesterol. The backbone of the receptor is shown in red, cholesterol mol-
ecules are shown in green, and the hydroxyl group in pink. POPC molecules are shown in
gray (with its phosphate group in white) and the surrounding water molecules in blue.
The ﬁgure represents one of the systems studied in ref. [64]. Adapted with permission
from Ref. [64] (copyright 2014 American Chemical Society).
Fig. 2. Diffusion of cholesterol molecules around the serotonin1A receptor in a membrane
bilayer of POPC and 30% cholesterol. The x and y coordinates of four representative choles-
terol molecules during the course of the simulation are shown in different colors. The
trajectories were ﬁtted using the receptor as the reference. The ﬁgure shows that several
cholesterol molecules (red, green and blue) sample a large part of the simulation box
(i.e., sample the bulk membrane), while a few (shown in black) bound to speciﬁc sites
show constrained dynamics.
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sampled. Fig. 2 depicts the sampling of a few randomly chosen choles-
terol molecules. The ﬁgure shows that one of the cholesterol molecules
(shown in green) diffuses freely throughout the simulation box, ap-
proaching the receptor several times but not interacting with it for
long periods of time. In contrast, the cholesterol molecule represented
in black interacts with the receptor for a substantial period of time.
The representative green cholesterol molecule, which undergoes fast
exchange with bulk lipids, could be indicative of annular lipids when
interacting with the receptor surface. The black cholesterol molecule,
on the other hand, could be representative of a nonannular lipid. From
such a cholesterol population distribution, we can identify regions of
high cholesterol density, often used as an indicator of cholesterol inter-
action sites. Sites of high cholesterol density are analogous to sites with
high total occupancy time, i.e., the time any cholesterol molecule was
bound at a site. The total occupancy time accounts for non-speciﬁc
cholesterol binding, and multiple binding/unbinding events with low
residency times, especially at high cholesterol concentrations. For this
reason, a second measure (the maximum occupancy time) was pro-
posed. The maximum occupancy time is deﬁned as the time a given
cholesterol molecule was bound to a particular site. Only speciﬁc
binding is accounted for the maximum occupancy time, especially at
high cholesterol concentrations. This measure could be viewed as a
distinguishing feature between the annular (high rate of exchange
with bulk lipids) and nonannular sites (low rate of exchange with the
bulk). With substantial sampling, both measures of high density and
maximum occupancy will identify the same sites, but could differ if
sampling is not adequate. It was shown in a related study [65] that in-
deed the site with the highest density corresponds to the site of high
maximum occupancy.By analyzing the maximum occupancy of cholesterol molecules at
different sites on the serotonin1A receptor, several cholesterol ‘hot-
spots’ could be identiﬁed [64]. These hot-spots correspond to the sites
at which the maximum occupancy was, on an average, higher than at
the remaining regions of the receptor. The cholesterol occupancy sites
were observed to be present on both the extracellular and the intracel-
lular side of the receptor. In another study, sub-microsecond time scale
simulation of the A2A adenosine receptor revealed a large number of
sites with increased cholesterol interaction [66]. Although the simula-
tions sampled shorter time scales, the atomistic force-ﬁeld used in the
study allowed a more detailed view of the cholesterol interaction. In
case of the β2-adrenergic receptor, several cholesterol interaction sites
were identiﬁed by two independent studies using atomistic and
coarse-grain approaches [65,67]. Interestingly, these sites exhibited
close agreement. It is therefore becoming clear that state-of-the-art
molecular dynamics simulations probing themicrosecond time scale re-
gime are able to identify cholesterol hot-spots on GPCRs. Taken togeth-
er, these studies indicate the presence of a large number of sites of high
cholesterol occupancy in GPCRs, indicative of nonannular sites.
3. Cholesterol hot-spots are dynamic in nature
The cholesterol hot-spots identiﬁed inGPCRs such as the serotonin1A
receptor [64], the A2A adenosine receptor [66] and the β2-adrenergic
receptor [65,67] appear to be highly dynamic. Most cholesterol mole-
cules exchange with bulk lipids within nanoseconds. Cholesterol mole-
cules were observed to be associated with the receptor in microsecond
time scale at the cholesterol hot-spots, i.e., the average lifetimes of the
interacting cholesterol molecules were of the order of microseconds
[64]. In a few shorter atomistic simulations, some cholesterol molecules
were observed to be stably bound throughout the simulation period
[67]. In general, the time scales of binding/unbinding at the hot-spots
are in the microsecond regime, while the association/dissociation oc-
curs at the nanosecond time scale at most other sites. Fig. 3 shows a
Fig. 3. Dynamics and diversity of cholesterol occupancy sites in GPCRs. A few sites show fast exchange with bulk membrane lipids and low occupancy at the receptor surface. Other sites
characteristically exhibit slow exchangewith bulk lipids and high occupancy at the GPCR surface. Fast nanosecond time scale dynamics is observed in several sites. Site hopping inmicro-
second time scale between proximal sites is also observed.
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serotonin1A receptor.
Even when ‘bound’ to the receptor, these sites are associated with
considerable cholesterol dynamics. The cholesterol molecules are
quitemobilewhen associatedwith the receptor and interactwith sever-
al residues in the vicinity. As a result, the pattern of the contact made at
each interaction site shows high variability [66]. For example, the cho-
lesterol hydroxyl group could interact with several nearby polar and
charged groups [64]. A few of the contacts could also be broken for
short time periods [68]. Interestingly, site hopping has also been ob-
served between sites that are close together in space [65]. The ﬂexibility
at the interaction site is also observed between different binding events,
and different association modes of the cholesterol molecule may be
sampled. Although limited sampling of themicrosecond time scale sim-
ulations could lead to differences between the occupancy at different
sites, similarities are observed in the nature of these sites. As a result,
we believe that these cholesterol hot-spots are indicative of ‘high occu-
pancy sites’ rather than ‘binding sites’.
4. Consensus sites of cholesterol interaction
The location of the cholesterol occupancy sites appears to be
receptor-dependent, although a few consensus sites are beginning to
emerge. Some of these sites are in deep protein pockets, and located
at the interface of transmembrane helices. One of the ﬁrst putative cho-
lesterol interaction sites was identiﬁed from crystallographic studies of
the β2-adrenergic receptor [8] and termed as the cholesterol consensus
motif (CCM). This site is located at the groove of the transmembrane he-
lices II and IV. The site is observed to correspond to high cholesterol oc-
cupancy in coarse-grain simulations [65], but suggested to be not as
frequently occupied in the atomistic simulations [67] of the β2-
adrenergic receptor. Cang et al. [67] showed using atomistic simulations
that only a single cholesterol molecule was associatedwith the receptor
at that site and the secondmolecule drifted away andwas replaced by a
phospholipid molecule. Further, high dynamics was observed in the
coarse-grain simulations at the CCM site and a microsecond time scale
interconversion was observed between this site and other nearby cho-
lesterol high-occupancy sites [65]. The CCM site was identiﬁed fromcrystal structures and could be speciﬁc to the crystallization conditions.
Interestingly, since this bindingmode correlateswell to that observed in
the simulation, it could indicate that cholesterol occupancy at this site is
independent of the lipid packing arrangement, although more dynamic
than suggested from crystallographic studies. In total, four sites were
identiﬁed at the extracellular side of the receptor andﬁve toward the in-
tracellular side [65,67]. A good agreement was found between most
high density sites identiﬁed in the coarse-grain [65] and atomistic [67]
simulations. Interestingly, high cholesterol density was observed at
the CCM site in atomistic simulations of the β1- adrenergic receptor
[69]. However, differences were observed in the cholesterol density at
the other cholesterol ‘hot-spots’.
The serotonin1A receptor displayed several cholesterol interaction
sites on the receptor surface [64]. Low cholesterol interaction was ob-
served at the corresponding CCM site at the cleft of transmembrane he-
lices II and IV. Another site suggested to be a putative cholesterol
interaction site is the cholesterol recognition amino acid consensus
(CRAC) site that has been identiﬁed in several GPCR sequences [70].
The cholesterol occupancy was on an average high at a CRAC site on
transmembrane helix V of the serotonin1A receptor in coarse-grain sim-
ulations [64]. However, cholesterol occupancy was high at several non-
CRAC sites including transmembrane helices I, II, VI and VII. Similar to
the adrenergic receptor family, the serotonin receptor family displays
differences in the cholesterol hot-spots. For example, high cholesterol
density was reported in the serotonin2A receptor at the intracellular
end of transmembrane helices I, II and IV, the extracellular side of trans-
membrane helices II and III, and at both termini of transmembrane he-
lices VI and VII [71].
Rhodopsin has been studied in several computational studies and
earlymolecular dynamics studies suggested that cholesterolwasmainly
excluded from the receptor surface [55,56]. More recent data suggest
the presence of high cholesterol density sites [57,72]. Khelashvili et al.
[57] and Horn et al. [72] identiﬁed different sites using atomistic and
coarse-grain approaches, but with an agreement in the cholesterol
high density site at transmembrane helix VII. The regions of high choles-
terol density identiﬁed in rhodopsin using coarse-grain approaches ap-
pear to closelymatchwith those in opsin [72]. One of these sites, located
at the cytoplasmic face of transmembrane helices III, IV and V, has also
er
gy
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tions were able to identify two additional sites at the extracellular side
of the receptor [66]. One of these siteswas substantiated by high choles-
terol density in a recent crystal structure of the A2A adenosine receptor
[10]. Interestingly, none of the above studies were able to discern high
cholesterol density at the CCM site.Cholesterol Occupancy Sites
En
kT
Fig. 4. A schematic representation of the energy landscape illustrating cholesterol interac-
tion sites inGPCRs. The landscape corresponds to a series of shallowminima interconnect-
ed by low energy barriers. The abscissa can be thought to correspond to individual
occupancy sites represented by each residue or by a sub-space at the receptor surface
(such as the CCM site). Although shown as interconnected, the sites are most likely to
be accessed via an exchange with the annular lipids and less often by direct site hopping.
Note that the energy barriers and the minima could be modulated by other membrane
components such as sphingolipids.5. Plasticity of cholesterol interaction
Several cholesterol interaction sites have been identiﬁed inGPCRs by
different computational studies. A comparison of these sites shows var-
iability between different sets and approaches, although some common
features emerge. The interaction of cholesterol with the cholesterol oc-
cupancy sites identiﬁed appears to be stochastic. Although on an aver-
age the same sites are sampled, the deviation between the actual
number of events sampled in the same time scales [66] and the time
of occupancy between different simulation sets is high [64]. Additional-
ly, as discussed earlier, a few contacts could also be broken for short
time periods, resulting in reduced occupancy at those sites [68]. Even
the ‘speciﬁc interaction’ of GPCRs with membrane cholesterol shows
high ﬂexibility in the probability of association. Although protein clefts,
charged or aromatic amino acids are involved in the interaction of cho-
lesterol with GPCRs, none of these are indispensable, and different com-
binations of these factors could provide diversity in cholesterol
occupancy sites [69]. It appears therefore that the interaction of choles-
terol with GPCRs is highly plastic.
The plasticity of GPCR-cholesterol interaction arises due to multiple
factors. The ﬁrst factor is the dynamics at the sites and between sites,
such that the interaction of the cholesterol molecules with individual
residues varies. A second factor is that the high occupancy sites could
have equal or comparable probability of cholesterol interaction, such
that there is a competition between these sites. The probability of occu-
pancy at these sites therefore could vary. To be able to discern these
small differences in the probabilities, a complete sampling of all possible
sites at themillisecond to second time scale is required. Yet another fac-
tor contributing to plasticity of cholesterol interaction sites is that some
of these could represent sites with competition with other lipid compo-
nents. A competition with phospholipids has been suggested for the
CCM site from atomistic simulations [67]. In addition, high occupancy
for both phospholipids and cholesterol at several sites has been report-
ed [64]. Interestingly, the presence or absence of other bilayer compo-
nents, such as sphingolipids, could additionally ﬁne-tune the plasticity
of cholesterol occupancy. The modulation of GPCR function by
sphingolipids has been demonstrated for the serotonin1A receptor [73,
74]. The plasticity of the cholesterol hot-spots could be dependent on li-
gand binding as well, and interestingly the high occupancy sites were
suggested to be ligand-dependent in the case of the adenosine2A recep-
tor [68] but not for the serotonin1A receptor [64].
The emerging model regarding the energy landscape of cholesterol
association with GPCRs is that it corresponds to a series of shallowmin-
ima interconnected by low barriers. A schematic view of the relative en-
ergy landscape of the cholesterol occupancy sites is shown in Fig. 4. The
cholesterol occupancy sites could be represented by individual residues
or by a sub-space at the receptor surface (such as the CCM site). Al-
though the occupancy sites are shown as interconnected, they are usu-
ally accessed via an exchange with the annular lipids and less often by
direct site hopping. The free energy of these sites, calculated from the
relative populations, is of the order of kT at room temperature [66].
The interaction energy between cholesterol and the receptor is relative-
ly low, although high cholesterol dynamics reduces the entropic penalty
of binding, thereby increasing the free energy of association at these
sites. Both the minima and the barriers could be modulated by other
lipid components. Ligand binding could further tune the energetics of
cholesterol interaction. Taken together, it is becoming clear that choles-
terol occupancy sites in GPCRs are weak, dynamic yet essential.6. Modulating GPCR structure and association
Although cholesterol interaction sites have been reported in GPCRs,
its effect on the structure and dynamics of GPCRs is still not clear. One of
the few studies focusing on protein structural integrity [57] reported
structural differences in the kink regions in transmembrane helices I, II
and VII. However, later work by Lyman and coworkers [68] analyzed
the effect of cholesterol on the A2A adenosine receptor and reported a
force-ﬁeld dependent dynamics of the kink regions. Another study
[71] correlated the functionally relevant conformational ﬂexibility of
the serotonin2A receptor with the interaction of cholesterol, but it was
not clear whether this conformational ﬂexibility was directly due to
the interaction of cholesterol. The differences in receptor structure aris-
ing from indirect effects, such asmembrane order, are less tractable and
have not been studied in a systematic manner. It appears that the effect
of cholesterol on receptor structure and dynamics is subtle and would
require more detailed analysis.
6.1. Interplay between direct and indirect effects
Long time scale simulations, especially using coarse-grain force-
ﬁelds, have allowed us to study GPCR association at a molecular level.
A pioneering study, focusing on rhodopsin organization in bilayers of
varying thickness, suggested that receptor association is inﬂuenced by
bilayer perturbations around the receptor [53]. The energy penalty
frommismatch between the hydrophobic length of the transmembrane
helices and the bilayer appears to be a driving factor for receptor oligo-
merization. A similar trend was reported for β1- and β2-adrenergic re-
ceptors, in which the mismatch was observed to be higher in the
presence of cholesterol [75]. The authors suggested that the increased
mismatch is related to the increased oligomerization in the presence
of cholesterol [75]. In both studies, a correlation was reported between
the helices with mismatch and their occurrence at oligomer interfaces
[53,75]. To address thedirect and indirect effects in amore tractable sys-
tem, the dimerization of the β2-adrenergic receptor was studied at dif-
ferent cholesterol concentrations [65,76]. Modulation of the dimer
interface was observed by increasing concentrations of cholesterol
(see Fig. 5). The presence of transmembrane helix IV at the dimer inter-
face was observed to be inversely correlatedwith the occupancy of cho-
lesterol at this site [65]. This was one of the ﬁrst studies that correlated a
Fig. 5.Modulation of the dimer interface of the β2-adrenergic receptor by membrane cholesterol content. Previous work using coarse-grainmolecular dynamics simulations showed that
the dimerization of the receptor is modulated bymembrane cholesterol content [65]. The receptor dimer interface changes from predominantly transmembrane helices IV and V (shown
in blue) at lowmembrane cholesterol to an interface consisting of transmembrane helices I and II (purple) at highmembrane cholesterol. Cholesterol is shown at the center in blue with
the polar hydroxyl group in red. Such conformational plasticity at the dimer interfacewith varying cholesterol content gives rise to interesting possibilities in future drug development
(see Ref. [65] for more details). Data taken from Ref. [65].
1780 D. Sengupta, A. Chattopadhyay / Biochimica et Biophysica Acta 1848 (2015) 1775–1782direct interaction of cholesterol with GPCR association. Similar to previ-
ous reports [53,75], the helices with a mismatch were observed at the
dimer interface. However, the population analysis did not completely
match the extent of the mismatch, i.e., the transmembrane helices
with the maximum mismatch were not necessarily those that were
maximally observed at the dimer interface [76]. These studies appear
to suggest that the driving forces for GPCR association are much more
complex than just hydrophobic mismatch or cholesterol occupancy.
Both direct and indirectmembrane effects contribute toward thedimer-
ization of the receptor. An examination of the energetics of several
dimer interfaces revealed similar energetics and several interfaces
were calculated to be favorable [54]. The comparable energetics of the
dimer interfaces, coupledwith the plasticity of the cholesterol occupan-
cy sites, could modulate dimer interfaces in a cholesterol-dependent
manner.7. Conclusions and future perspectives
Multi-scale simulations have shown that membrane cholesterol
preferentially interacts with certain sites on GPCRs. Nonetheless, the as-
sociation of cholesterol to membrane proteins in general, and GPCRs in
particular, is currently being extensively explored. A general picture of
cholesterol interaction sites is emerging, although no consensus model
has been reached. The cholesterol interaction sites represent hot-spots
that are reminiscent of high occupancy sites, instead of binding sites.
Several such high occupancy sites are present at the surface of GPCRs.
Cholesterol molecules at these hot-spots exhibit microsecond time
scale lifetimes and exhibit fast exchange with bulk lipids. At the high
occupancy sites, cholesterol molecules exhibit fast dynamics and
stochasticity is observed in the characteristic interaction patterns. The
plasticity in the cholesterol occupancy sites appears to be related to
the low but comparable energetics of the different sites, and competi-
tion with other bilayer components. Although cholesterol-rich bilayers
are observed to directly affect receptor organization, the effects on the
structure and dynamics of the receptor are less clear. The driving force
of receptor organization is complex and both hydrophobic mismatchand cholesterol sites contribute to GPCR oligomerization. Membrane
cholesterol effects on receptor structure and organization, that could
modulate drug efﬁcacy, represent a new frontier in GPCR research.
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